Medpace (MEDP) Stock Forecast & Price Target
Score
Medpace Holdings, Inc. price target
| MEDP | |
|---|---|
| Low | $515.00 |
| Average | $646.90 |
| High | $730.00 |
| Upside vs current price | -1.5% |
The average target of $646.90 is -1.5% versus the current MEDP price of $656.84.
Medpace Holdings, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 1 |
| Hold | 11 |
| Sell | 1 |
| Strong sell | 0 |
| Consensus | Hold |
14 analysts cover MEDP.
Medpace Holdings, Inc. EPS and revenue estimates
MEDP shows the next fiscal years with at least three analysts: 2026 EPS $18.24, 2027 EPS $19.70. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $18.24 | $2.85B |
| 2027 | $19.70 | $3.02B |
Is Medpace Holdings, Inc. a buy or sell?
Of the 14 analysts covering Medpace Holdings, Inc., 2 rate it a buy (1 strong buy and 1 buy), 11 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).
The MEDP consensus label is Hold, beside 2 buy-side ratings and 1 sell-side ratings.
The average target of $646.90 implies -1.5% versus the current price of $656.84.
Those 14 ratings on MEDP are a headcount, and the label on file is Hold.
Reading the Medpace Holdings, Inc. forecast
The MEDP target band runs from $515.00 to $730.00. The average inside that band is $646.90.
Set next to the $656.84 MEDP quote, that average is -1.5%.
Ratings on the Medpace Holdings, Inc. cluster: 2 of 14 analysts are on the buy side, 11 are at hold, and 1 is on the sell side, and the published consensus is Hold.
Recent MEDP revisions are two-sided: 1 upgrades and 0 downgrades.
The MEDP average target is little changed, $679.00 over the last month and $678.33 over the last quarter.
Only 14 analysts cover MEDP, so the average rests on a short list.
Medpace Holdings, Inc. forecast questions
What is the MEDP price target?
The published range for MEDP is $515.00 to $730.00, with an average of $646.90. That average is -1.5% versus the current price of $656.84.
Is Medpace Holdings, Inc. a buy or sell?
Of the 14 analysts covering Medpace Holdings, Inc., 2 rate it a buy, 11 rate it a hold, and 1 rates it a sell. The consensus is Hold, and the MEDP headcount is 2 buy, 11 hold, and 1 sell.
What is the EPS estimate for Medpace Holdings, Inc.?
Analyst EPS estimates for Medpace Holdings, Inc.: 2026 $18.24, 2027 $19.70.
What is the revenue estimate for Medpace Holdings, Inc.?
Analyst revenue estimates for Medpace Holdings, Inc.: 2026 $2.85B, 2027 $3.02B.
How many analysts cover MEDP?
14 analysts cover MEDP. Their consensus on MEDP is Hold, across those 14.